Quadrivalent flu jab launched

Sanofi Pasteur recently launched a quadrivalent influenza vaccine in the UK that protects against two A and two B strains.

The company says that two strains of influenza B have been consistently co-circulating during recent flu seasons. “By adding protection against the additional B strain, these innovative vaccines help address the unpredictable nature of B strain circulation, thus broadening protection against influenza.”

Recommended

Clinical review: Antihypertensive medication

NICE recommends Tremfya




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.